West Pharmaceutical Services WST Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Proprietary Products | $2.62B+12.2% | $2.49B+6.8% | $2.44B+5.6% | $2.4B+3.6% | $2.34B-1.5% | |
| Concentration risk, percentage by Product | ||||||
| Standard Packaging | 52%-7.0pp | 55%+7.0pp | 57%+8.0pp | 61%+17.0pp | 59%+14.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does West Pharmaceutical Services break its business down?
- West Pharmaceutical Services (WST) reports net sales by business across 2 parts — Proprietary Products and West Vantage. Each is extracted from the segment footnotes and tracked over time.
- Where does West Pharmaceutical Services's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in West Pharmaceutical Services's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
